Sfoglia per AUTORE
LISI C
Collezione ASL Vercelli
Items : 2
A multi-center comparative study of Atezolizumab plus Bevacivumab and Lenvatinib as primary systemic therapy for unresectable hepatocellular carcinoma (HCC): focus on thrombotic and hemorrhagic adverse events in Digestive and Liver Disease
2024
ASL Vercelli
ASL Vercelli
Tizzani M; Mazzarelli C; Burlone M; Carucci P; Caviglia GP; Lisi C; Canalis C; Cesarini L; Pirisi M; Acquaviva A; Rolle E; Pochettino P; Bencardino K; Villa F; Angiolillo M; Scaldaferri M; Castellana E; Cattel F; Airoldi M; Saracco GM; Gaia S;
Glomerular filtration rate: A prognostic marker in atrial fibrillation—A subanalysis of the AntiThrombotic Agents Atrial Fibrillation in Clinical Cardiology
2018
ASL Vercelli
ASL Vercelli
Proietti R; Gonzini L; Pizzimenti G; Ledda A; Sanna P; AlTurki A; Russo V; Lencioni M; Siciliano R; Boffa M; Bazzanini F; Di Nucci G; Fonti S; De Franceschi T; Davio P; Alagna G; Cipollini F; Arma P; Gunnellini MG; Dottori M; Paulillo D; Giudice M; Sicuro M; Lenti S; Iannelli G; Notarstefano P; Galiotto M; Apolloni E; Molini G; et alii...


